Addiction Medicine — Medicare Part B billing by state
39 physician groups whose primary specialty is Addiction Medicine billed $4.6M to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Oklahoma | $1.3M | $1.2M | 1 | $1.2M | 43,473 | 6,533 | 43,473 |
| Minnesota | $764K | $741K | 1 | $741K | 11,403 | 3,587 | 11,403 |
| Tennessee | $347K | $317K | 5 | $63K | 12,766 | 6,550 | 2,553 |
| Ohio | $337K | $326K | 4 | $81K | 5,496 | 1,991 | 1,374 |
| Arizona | $258K | $260K | 1 | $260K | 17,605 | 89 | 17,605 |
| Rhode Island | $216K | $215K | 1 | $215K | 4,268 | 3,520 | 4,268 |
| Virginia | $200K | $188K | 5 | $38K | 2,841 | 1,054 | 568 |
| Pennsylvania | $192K | $188K | 1 | $188K | 3,432 | 2,175 | 3,432 |
| Massachusetts | $181K | $188K | 2 | $94K | 2,695 | 1,558 | 1,348 |
| Indiana | $150K | $137K | 2 | $68K | 2,606 | 911 | 1,303 |
| California | $125K | $129K | 2 | $64K | 2,119 | 657 | 1,060 |
| Maryland | $122K | $126K | 3 | $42K | 1,767 | 594 | 589 |
| Georgia | $96K | $96K | 2 | $48K | 1,059 | 229 | 530 |
| Vermont | $95K | $91K | 2 | $45K | 1,457 | 307 | 728 |
| Florida | $93K | $96K | 3 | $32K | 1,456 | 396 | 485 |
| Kentucky | $65K | $58K | 2 | $29K | 895 | 431 | 448 |
| Texas | $42K | $34K | 2 | $17K | 412 | 117 | 206 |
| District of Columbia | $32K | $32K | 1 | $32K | 348 | 231 | 348 |
| Missouri | $30K | $26K | 1 | $26K | 487 | 140 | 487 |
| Michigan | $29K | $27K | 2 | $13K | 409 | 258 | 204 |
| New Jersey | $26K | $27K | 1 | $27K | 483 | 82 | 483 |
| New York | $25K | $26K | 2 | $13K | 382 | 220 | 191 |
| Maine | $19K | $18K | 1 | $18K | 230 | 184 | 230 |
| New Mexico | $19K | $18K | 1 | $18K | 305 | 104 | 305 |
| North Carolina | $12K | $11K | 1 | $11K | 173 | 44 | 173 |
| Washington | $5K | $6K | 1 | $6K | 53 | 13 | 53 |
| Hawaii | $3K | $3K | 1 | $3K | 38 | 12 | 38 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
8 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| G0481 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $442K | 2,929 | OKMNTNOHAZ |
| G0482 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $249K | 1,276 | OKMNTNOHAZ |
| J2356 · Injection, tezepelumab-ekko, 1 mg | $224K | 15,750 | OKMNTNOHAZ |
| G2211 · Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's top by services | $76K | 7,421 | OKMNTNOHAZ |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $2K | 19,813 | OKMNTNOHAZ |
| J2250 · Injection, midazolam hydrochloride, per 1 mg top by services | $594 | 6,158 | OKMNTNOHAZ |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $426 | 4,950 | OKMNTNOHAZ |
| J1010 · Injection, methylprednisolone acetate, 1 mg top by services | $312 | 3,443 | OKMNTNOHAZ |